Phibro Animal Health EV/EBIT PAHC

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2015.

Today, Oct 23, 2026: 11.7×
10-year median: 14.2×
Against its 10-year history: 23rd; percentile: 0 is its lowest day, 100 its highest
10-year range: 1.7× to 22.1×
Peer median: 8.5×

Phibro Animal Health's EV/EBIT is 11.7× as of Oct 23, 2026.

That is below its ten-year median of 14.2×, lower than on 77% of days in the last ten years.

Over that time it ranged from 1.7× in May 2026 to 22.1× in Aug 2018.

The median for 10 large drugmakers of a similar size is 8.5×.

EV/EBIT over time

median 14.2×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	11.7×	1.7×	11.7×
2025	2.0×	2.0×	16.1×
2024	13.0×	11.6×	19.8×
2023	12.3×	9.6×	12.3×
2022	9.6×	9.1×	14.4×
2021	14.0×	13.1×	18.2×
2020	12.4×	11.4×	19.6×
2019	16.2×	11.8×	16.2×
2018	14.4×	14.4×	22.1×
2017	14.9×	14.6×	18.8×
2016	16.0×	11.1×	18.6×
2015	16.7×	16.7×	22.5×

Against its peers

Companies in Drug Manufacturers - General nearest Phibro Animal Health's size, closest first, today.

Company	EV/EBIT
PAHCPhibro Animal Health	11.7×
ANIPANI Pharmaceuticals	10.5×
ANABAnaptysbio	n/m
PCRXPacira BioSciences	7.6×
OMEROmeros	n/m
HRMYHarmony Biosciences	6.9×
PBHPrestige Consumer Healthcare	14.5×
AMPHAmphastar Pharmaceuticals	12.2×
NRIXNurix Therapeutics	7.1×
ABUSArbutus Biopharma	4.9×
COLLCollegium Pharmaceutical	9.4×
Peer median	8.5×

Where Phibro Animal Health ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Phibro Animal Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.